KINETICS OF MINIMAL RESIDUAL DISEASE BEFORE AND AFTER HEMATOPOIETIC CELL TRANSPLANTATION
Introduction: Minimal residual disease (MRD) detected before and after hematopoietic stem cell transplantation (HSCT) is associated with poor outcomes in high-risk acute leukemia. This study prospectively evaluates the impact of MRD accessed by multiparameter flow cytometry (MFC) in a reference hosp...
| Published in: | Hematology, Transfusion and Cell Therapy |
|---|---|
| Main Authors: | AP Azambuja, Y Schluga, JLP Justus, MP Beltrame, M Malvezzi, VAM Funke, R Pasquini, CMS Bonfim |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923007939 |
Similar Items
PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL) OR BLASTIC CRISIS OF CHRONIC MYELOID LEUKEMIA (CML-BC)?
by: AP Azambuja, et al.
Published: (2024-10-01)
by: AP Azambuja, et al.
Published: (2024-10-01)
Impact of high-sensitivity flow cytometry on peri-transplant minimal residual disease kinetics in acute leukemia
by: Ana Paula de Azambuja, et al.
Published: (2025-02-01)
by: Ana Paula de Azambuja, et al.
Published: (2025-02-01)
MINIMAL RESIDUAL DISEASE AND HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE
by: AP Azambuja
Published: (2024-10-01)
by: AP Azambuja
Published: (2024-10-01)
Minimal residual disease and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01)
by: I. V. Galtseva, et al.
Published: (2024-12-01)
Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
by: Daniela Hespanha Marinho, et al.
Published: (2015-08-01)
by: Daniela Hespanha Marinho, et al.
Published: (2015-08-01)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
by: Sarah A. Buckley, et al.
Published: (2017-05-01)
by: Sarah A. Buckley, et al.
Published: (2017-05-01)
STUDY OF MINIMAL RESIDUAL DISEASE BY MULTICOLOR FLOW CYTOMETRY IN MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: I. V. Galtseva, et al.
Published: (2017-06-01)
by: I. V. Galtseva, et al.
Published: (2017-06-01)
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by: Adriana Balduzzi, et al.
Published: (2025-08-01)
by: Adriana Balduzzi, et al.
Published: (2025-08-01)
Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation
by: Szymon Skoczeń, et al.
Published: (2020-04-01)
by: Szymon Skoczeń, et al.
Published: (2020-04-01)
PADRÕES DE APRESENTAÇÃO DO CLONE HPN NA HEMÓLISE INTRA E EXTRAVASCULAR E RESPOSTA AO TRATAMENTO COM TRÊS INIBIDORES DE COMPLEMENTO
by: AP Azambuja, et al.
Published: (2024-10-01)
by: AP Azambuja, et al.
Published: (2024-10-01)
Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
by: Maura Rosane Valério Ikoma, et al.
Published: (2015-12-01)
by: Maura Rosane Valério Ikoma, et al.
Published: (2015-12-01)
MATCHED-SIBLING, MATCHED-UNRELATED, OR HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LEUKEMIAS AND MYELODYSPLASIA IN BRAZIL: A PROSPECTIVE MULTICENTER STUDY IN COLLABORATION WITH THE CIBMTR
by: LJ Arcuri, et al.
Published: (2024-10-01)
by: LJ Arcuri, et al.
Published: (2024-10-01)
TRANSPLANTE ALOGÊNICO DE CÉLULAS-TRONCO HEMATOPOIÉTICAS NA ERA DOS INIBIDORES DE TIROSINO-QUINASE: SEGUIMENTO DE 20 ANOS
by: GRO Medeiros, et al.
Published: (2023-10-01)
by: GRO Medeiros, et al.
Published: (2023-10-01)
Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
by: Hee-Je Kim, et al.
Published: (2021-06-01)
by: Hee-Je Kim, et al.
Published: (2021-06-01)
Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: S. A. Tuchman, et al.
Published: (2012-01-01)
by: S. A. Tuchman, et al.
Published: (2012-01-01)
Study on Fractionated Total Body Irradiation before Hematopoietic Stem Cell Transplantation
by: Tong FANG, et al.
Published: (2009-02-01)
by: Tong FANG, et al.
Published: (2009-02-01)
Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation
by: Marie-Julia Ziliotis, et al.
Published: (2024-04-01)
by: Marie-Julia Ziliotis, et al.
Published: (2024-04-01)
RELATO DE CASO: LEUCEMIA MIELOIDE CRÔNICA APRESENTANDO-SE COM CRISE BLÁSTICA MIELOIDE E SARCOMA GRANULOCÍTICO EM PELE
by: PHA Silva, et al.
Published: (2024-10-01)
by: PHA Silva, et al.
Published: (2024-10-01)
Neurological complications of hematopoietic stem cell transplantation (HSCT): a retrospective study in a HSCT center in Brazil Complicações neurológicas do transplante de células tronco hematopoiéticas (TCTH): estudo retrospectivo em um centro de TCTH no Brasil
by: Hélio A.G. Teive, et al.
Published: (2008-01-01)
by: Hélio A.G. Teive, et al.
Published: (2008-01-01)
PREVALENCE OF RENAL DISFUNCTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA USING FIRST AND SECOND-GENERATION TYROSINE KINASE INHIBITORS
by: JL Celestino, et al.
Published: (2023-10-01)
by: JL Celestino, et al.
Published: (2023-10-01)
DESCONTINUAÇÃO DE TRATAMENTO EM PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA, COM RESPOSTA MOLECULAR PROFUNDA E EFEITOS ADVERSOS RELACIONADOS AO INIBIDORES DE TIROSINA QUINASE
by: JL Celestino, et al.
Published: (2024-10-01)
by: JL Celestino, et al.
Published: (2024-10-01)
COMPARISON OF OUTCOMES AFTER MATCHED RELATED, UNRELATED AND HAPLOIDENTICAL DONOR BONE MARROW TRANSPLANTATION FOR PATIENTS WITH ACQUIRED APLASTIC ANEMIA: A MULTICENTER RETROSPECTIVE ANALYSIS OF REAL-WORLD EXPERIENCE IN BRAZIL
by: R Marchesini, et al.
Published: (2023-10-01)
by: R Marchesini, et al.
Published: (2023-10-01)
PB2443: APPLICABILITY OF SHORT TANDEM REPEAT (STR) IN LEUKEMIA PATIENTS RECEIVED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE ERA OF MINIMAL RESIDUAL DISEASE (MRD)
by: Juhyung Kim, et al.
Published: (2023-08-01)
by: Juhyung Kim, et al.
Published: (2023-08-01)
Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia
by: Izaskun Elorza, et al.
Published: (2010-06-01)
by: Izaskun Elorza, et al.
Published: (2010-06-01)
OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA PATIENTS WITH ACTIVE REFRACTORY DISEASE BEFORE TRANSPLANT
by: FS Azevedo, et al.
Published: (2024-10-01)
by: FS Azevedo, et al.
Published: (2024-10-01)
Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria
by: Giorgia Battipaglia, et al.
Published: (2019-08-01)
by: Giorgia Battipaglia, et al.
Published: (2019-08-01)
IMPACTO DA RECAÍDA E PERFIL MUTACIONAL NA SOBREVIDA DE PACIENTES COM LEUCEMIA MIELÓIDE CRÔNICA (LMC) EXPOSTOS A INIBIDORES DE TIROSINO QUINASE (ITQ) E SUBMETIDOS A TRANSPLANTE DE CÉLULAS-TRONCO HEMATOPOIÉTICAS (TCTH): UMA ANÁLISE DE LONGO PRAZO
by: VAM Funke, et al.
Published: (2024-10-01)
by: VAM Funke, et al.
Published: (2024-10-01)
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
by: Baptiste Le Calvez, et al.
Published: (2024-07-01)
by: Baptiste Le Calvez, et al.
Published: (2024-07-01)
Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation
by: Eleni Gavriilaki, et al.
Published: (2021-02-01)
by: Eleni Gavriilaki, et al.
Published: (2021-02-01)
Allogeneic hematopoietic stem cell transplantation for primary myelodysplastic syndrome Transplante alogênico de células progenitoras hematopoiéticas para síndrome mielodisplásica primária
by: Carlos R. Medeiros, et al.
Published: (2004-01-01)
by: Carlos R. Medeiros, et al.
Published: (2004-01-01)
LESÕES CUTÂNEAS EM UM PACIENTE COM LEUCEMIA MIELOIDE CRÔNICA EM USO DE DASATINIBE: UM RELATO DE CASO
by: JL Celestino, et al.
Published: (2024-10-01)
by: JL Celestino, et al.
Published: (2024-10-01)
The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study
by: Xiya Wei, et al.
Published: (2022-08-01)
by: Xiya Wei, et al.
Published: (2022-08-01)
Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
by: Hakan Göker, et al.
Published: (2011-08-01)
by: Hakan Göker, et al.
Published: (2011-08-01)
Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
by: Hakan Göker, et al.
Published: (2011-09-01)
by: Hakan Göker, et al.
Published: (2011-09-01)
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia
by: Razan Mohty, et al.
Published: (2023-02-01)
by: Razan Mohty, et al.
Published: (2023-02-01)
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group
by: Maddalena Benetton, et al.
Published: (2022-06-01)
by: Maddalena Benetton, et al.
Published: (2022-06-01)
INFLUENCE OF INTERLEUKIN-12 (IL-12) ON MINIMAL RESIDUAL DISEASE (MRD) OF MULTIPLE MYELOMA PATIENTS TREATED WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION: EXPERIENCE FROM A SINGLE BONE MARROW TRANSPLANT SERVICE
by: AF Callera, et al.
Published: (2024-10-01)
by: AF Callera, et al.
Published: (2024-10-01)
PB2447: PREEMPTIVE TREATMENT WITH PD-1 ANTIBODY FOR ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME WITH POSITIVE MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Ling MA, et al.
Published: (2023-08-01)
by: Ling MA, et al.
Published: (2023-08-01)
Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China
by: Zhe Ding, et al.
Published: (2015-01-01)
by: Zhe Ding, et al.
Published: (2015-01-01)
Fecal microbiota transplantation before hematopoietic stem cell transplantation in a pediatric case of chronic diarrhea with a FOXP3 mutation
by: Wenyan Wu, et al.
Published: (2021-03-01)
by: Wenyan Wu, et al.
Published: (2021-03-01)
Similar Items
-
PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL) OR BLASTIC CRISIS OF CHRONIC MYELOID LEUKEMIA (CML-BC)?
by: AP Azambuja, et al.
Published: (2024-10-01) -
Impact of high-sensitivity flow cytometry on peri-transplant minimal residual disease kinetics in acute leukemia
by: Ana Paula de Azambuja, et al.
Published: (2025-02-01) -
MINIMAL RESIDUAL DISEASE AND HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE
by: AP Azambuja
Published: (2024-10-01) -
Minimal residual disease and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01) -
Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
by: Daniela Hespanha Marinho, et al.
Published: (2015-08-01)
